is bpc 157 banned by usada Peptides for Runners: What Exactly BCP-157? Pro ultrarunner opens up about

There is no controlled human trial data on these combinations

It did not provide a separate standardised assessment of an arginate material

This represents a key mechanism by which tirzepatide produces greater weight loss than diet alone despite similar caloric restriction

others pay significantly less or deny the code outright for certain plan types

Why Compounding Access Is Not an Established Path Positioning in the Metabolic Medicine Conversation For physicians fielding patient questions about 5-amino-1MQ, the appropriate framing: Promising mechanism with solid preclinical rationale Early clinical development human efficacy and safety not yet well characterized No legitimate clinical access pathway in the United States as of 2026 Alternative evidence-based options exist for the underlying metabolic optimization goals patients typically pursue Key Takeaways 5-amino-1MQ is a small-molecule NNMT inhibitor, not a peptide